tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

IMGO

Merck completes tender offer to acquire Imago BioSciences
The FlyMerck completes tender offer to acquire Imago BioSciences
5M ago
MRK
IMGO
Imago BioSciences:1st participant dosed in bomedemstat/ruxolitinib study for MF
The FlyImago BioSciences:1st participant dosed in bomedemstat/ruxolitinib study for MF
6M ago
IMGO
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in Myelofibrosis
Press ReleasesImago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in Myelofibrosis
6M ago
IMGO
Eight new option listings and one option delisting on December 14th
The FlyEight new option listings and one option delisting on December 14th
6M ago
CBNK
IMGO
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022
Press ReleasesImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022
6M ago
IMGO
Imago BioSciences presents data from Phase 2 study of bomedemstat in ET
The FlyImago BioSciences presents data from Phase 2 study of bomedemstat in ET
6M ago
IMGO
Imago BioSciences presents data from ongoing Phase 2 study of bomedemstat
The FlyImago BioSciences presents data from ongoing Phase 2 study of bomedemstat
6M ago
IMGO
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022
Press ReleasesImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022
6M ago
IMGO
Imago BioSciences says 1st patient dosed in bomedemstat combo study for AML
The FlyImago BioSciences says 1st patient dosed in bomedemstat combo study for AML
6M ago
IMGO
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia
Press ReleasesImago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia
6M ago
IMGO
Imago BioSciences downgraded to Hold from Buy at Stifel
The FlyImago BioSciences downgraded to Hold from Buy at Stifel
6M ago
IMGO
Merck Snaps Up Imago for $1.35 Billion; Stock Up 100%
Market NewsMerck Snaps Up Imago for $1.35 Billion; Stock Up 100%
7M ago
MRK
IMGO
Imago BioSciences reports Q3 EPS (50c), consensus (44c)
The FlyImago BioSciences reports Q3 EPS (50c), consensus (44c)
7M ago
IMGO
Imago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business Updates
Press ReleasesImago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business Updates
7M ago
IMGO
Imago BioSciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Press ReleasesImago BioSciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
9M ago
IMGO
Imago BioSciences to Participate in the 2022 Wedbush PacGrow Healthcare Conference
Press ReleasesImago BioSciences to Participate in the 2022 Wedbush PacGrow Healthcare Conference
10M ago
IMGO
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at EHA 2022
Press ReleasesImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at EHA 2022
12M ago
IMGO
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at EHA 2022
Press ReleasesImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at EHA 2022
12M ago
IMGO
Imago BioSciences to Host Virtual Investor Event
Press ReleasesImago BioSciences to Host Virtual Investor Event
1y ago
IMGO